- Deal Lead, Wellington Access Ventures
United States, Institutional
Change
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
In the ever-evolving world of venture capital (VC), change is the only constant. Over recent months, VC markets have taken an interesting turn, and founders are finding themselves facing two key implications:
- Capital raises just got tougher, and
- The growth-at-any-cost era is behind us
To chart a course through this capital-scarce landscape, we propose a new guiding star: growth efficiency. It's time to explore why growth efficiency matters, especially for diverse and underrepresented founders.
Why growth efficiency matters for the next generation of entrepreneurs
Diverse and underrepresented founders often face an uphill battle when seeking access to capital. Shockingly, a mere 1% of venture capital finds its way to Black-founded companies1 and less than 3% goes to female founders.2 This underscores the imperative for diverse and historically overlooked founders to showcase robust growth efficiency metrics.
Enhancing growth efficiency serves a dual purpose. It not only broadens your access to capital but also reins in your burn rate, reducing your reliance on venture assets and bolstering your readiness for the future.
Metrics that matter to the VC world
But what metrics should you focus on to turbocharge your growth efficiency? Amid a sea of options, we highlight two key metrics: growth efficiency and the Magic Number.
Metric #1: Growth efficiency — the gold standard
This metric is the heartbeat of your business's growth efficiency. Ideally, your company should aim for a growth efficiency of 1.0 or higher, signifying that for every dollar invested, you're generating a dollar in revenue. However, this is a target to work toward; your business doesn't need to hit 1.0 overnight.
What matters is demonstrating a positive trend toward higher growth efficiency and explaining the steps you're taking to enhance this metric. VC firms often look closely at this trend line to understand if your improvements stem from cost reductions or more efficient customer acquisition. Mastering this growth efficiency metric helps you communicate that your company is on the right trajectory.
Metric #2: The Magic Number — honing in on sales efficiency
The Magic Number peels back the layers of your go-to-market strategy, highlighting your sales efficiency. A figure above 1.0 signifies a highly efficient sales effort, while anything below 0.5 signals room for improvement. A full grasp of this metric empowers you to pinpoint both strengths and inefficiencies in your sales process and to identify where investments or changes may be warranted.
For instance, a low Magic Number might prompt you to streamline or redirect aspects of your sales strategy, whereas a high Magic Number could justify increased investments in marketing and sales to leverage your sales efficiency.
Bottom line: The age of growth efficiency in venture capital
For those who embarked on entrepreneurial journeys in recent years, growth efficiency might not have been a top priority in the prior regime of unbridled expansion. However, for early-stage diverse and underrepresented founders today, these metrics can be transformative. They not only can distinguish your company but also remain indispensable throughout its life cycle.
Investors in private equity and public markets closely scrutinize how a company's growth efficiency measures up against peers. Context is key; these metrics gain significance when aligned with your company's specific circumstances and growth prospects. You are the foremost authority on your business, so understanding the factors driving any inefficiencies and profiling how your team is steering toward more efficient growth is paramount.
We stand alongside our portfolio companies on this journey. As you navigate the constantly shifting landscape of venture capital, we are here to collaborate and facilitate your effort to unlock your full potential in this new VC era. The rules of the game are rapidly evolving — let's embrace the change.
1Source: TechCrunch, ‘The old guard in venture reigns supreme’. 2 August 2023. | 2Source: Deloitte, “Diversity in Venture Capital – VC Human Capital Survey.” Fourth edition conducted in 2022.
Stay up to date with the latest market insights and our point of view.
Showing
of
Insights Posts
Article
5 min
Private credit outlook for 2026: 5 key trends
Our private credit experts discuss five themes driving the asset class’s 2026 outlook, including public/private convergence, changing credit profiles, the growth of retail, and much more.
5 min
Article
2026-12-31
Article
5 min
Venture capital outlook for 2026: 5 key trends
We explore 2026's venture capital trends, highlighting IPO momentum, M&A acceleration, secondary market growth, public-private convergence, and the focus on quality investments.
5 min
Article
2026-12-31
Video
8 min
Private real estate debt: An evolving opportunity set
In our latest Insurance Quick Takes video, Fixed Income and Global Insurance Strategist Amar Reganti talks to Ravi Anand, Portfolio Manager and Head of Private Real Estate Credit. They discuss trends driving interest in private real estate and the diversification opportunity the asset class may offer insurers.
8 min
Video
2026-11-30
Article
6 min
Investing in climate solutions across public and private markets
Collaboration between public and private market investors can be powerful. Opportunities where expertise and resources can be shared to accelerate innovation and deployment are optimal. Our experts explore how AI, geopolitics, and global policy are reshaping climate solutions across sectors.
6 min
Article
2026-10-14
Article
7 min
Human capital management for private companies
We discuss why effective people management is critical for private companies and outline four strategic focus areas that can help companies navigate evolving employee needs, regulatory changes, and investor expectations.
7 min
Article
2026-11-30
Article
5 min
What’s the Fed got to do with it? The impact of rate cuts on CLO equity
Our CLO experts discuss the implications of Fed rate cuts on CLO equity, emphasizing its potential to maintain income amidst rate sensitivity challenges in other credit assets.
5 min
Article
2026-10-31
Article
6 min
Commercial real estate debt: Transitional assets deep dive
Our private commercial real estate debt experts explore transitional CRE assets, highlighting their key characteristics, how they differ from other parts of the CRE debt universe, their potential roles in a portfolio, and much more.
6 min
Article
2026-10-31
Article
10 min
Venture and growth equity: The future of private-market evergreen funds?
Investment Director Cara Hubbard highlights how the VC and growth equity landscapes are transforming, details the rising popularity of evergreen funds, and shares how these themes may converge to expand access to private markets.
10 min
Article
2026-10-31
Article
7 min
Investment-grade private credit market deep dive
Emeka Onukwugha and Elisabeth Perenick explore the evolving investment-grade private credit market, highlighting its key characteristics, liquidity profile, roles in a portfolio, and much more.
7 min
Article
2026-10-31
Video
2 min
Collaboration in practice: Late-stage growth
Matt Witheiler, Head of Late-stage Growth, explores the impact of Wellington’s collaborative culture. He highlights the potential benefits of working with his private-market colleagues across sectors and stages as well as leveraging Wellington’s hundreds of public-market experts.
2 min
Video
2026-09-30
Video
2 min
Collaboration in practice: Late-stage biotech
Nilesh Kumar, Head of Biotech Private Investing, explores how working with Wellington’s public-market biotech experts helps his team better understand the feasibility of emerging biotech innovations.
2 min
Video
2026-09-30
URL References
Related Insights